The Multiple Myeloma Treatment Simulator
Sharpen your skills in the Multiple Myeloma (MM) Treatment Simulator! It’s an innovative approach to CME/CNE. You’ll acquire state-of-the art knowledge of MM management by treating virtual patients with highly realistic presentations of MM and associated conditions. You work in a “risk free” environment and get valuable feedback on each treatment decision you make.
The MM simulator was developed through collaboration between the National Comprehensive Cancer Network® (NCCN®) and Syandus Inc. The NCCN designates this enduring activity for a maximum of 3.0 AMA PRA Category 1 Credit(s)™ and a maximum of 3.0 contact hours for continuing nursing education. CME/CE information is provided within the application.
This activity is supported by educational grants from CELGENE CORPORATION; Novartis Oncology; Takeda Oncology and by a grant from Onyx Pharmaceuticals.
About MM Treatment Simulator:
• Absolutely FREE – no cost to download, no in-app purchases
• Designed for oncologists, nurses, and other health care professionals who manage patients with multiple myeloma
• All content is based on NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) with significant input from renowned medical hematologist-oncologists
• Provides a powerful “experience-based” learning environment where you devise a treatment plan and select therapies based on virtual patient needs
• Each treatment decision you make is accompanied by intelligent feedback that helps pinpoint clinical nuances of available treatment options and efficiently improve your MM management skills as a whole
• You learn about state-of-the-art MM management from experts but at your own pace and in a stress-free environment
• NCCN and Syandus respect your privacy and confidentiality. The privacy statement for this activity is available from within the application.
Features:
• Simple, one touch interaction throughout the app
• Multiple interactive areas that are explored to discover information on cases, treatments and other clinically relevant components, including NCCN recommended treatment guidelines
• Features 7 highly realistic scenarios that cover diverse multiple myeloma presentations, including stem cell transplant eligible and ineligible, newly diagnosed and relapsed myeloma patients with a wide range of associated conditions
• Scenarios can be reworked multiple times
Support:
Questions? Comments? Concerns? Go to http://www.alivemed.com/Support